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Objectives: Patients with diabetes exhibit an increased risk of heart failure. Berberine
is a major isoquinoline alkaloid, which is the most abundant constituent of Chinese
herb Rhizoma coptidis, exerts anti-inﬂammatory effects in various disease models and
prevents diarrheic and inﬂammation in humans. Berberine may exert cardioprotective
effect against myocardial injury and dysfunction in diabetes. In this study, we
investigated the effects of berberine on myocardial dysfunction, ﬁbrosis, and
inﬂammation using a rat model of diabetic cardiomyopathy and primary neonatal rat
cardioﬁbroblasts exposed to high glucose and TGF-b.
Methods: Rats were randomized to receiving saline or berberine treatment (200
mg$kg-1$d-1, gavage) for 4 wks. Left ventricular function was measured by echo-
cardiography. Fibrosis and inﬂammation markers were evaluated by molecular
biology/biochemical techniques.
Results: Diabetic cardiomyopathy was characterized by declined LV ejection frac-
tions and decreased LV volumes associated with increased MAPK (JNK and P-38)
activation, enhanced expression of adhesion molecules ICAM-1, TNF-a, markers of
ﬁbrosis (TGF-b, CTGF, ﬁbronectin, collagen expression, MMP-2 and MMP-9), and
diminished AMPK, Akt and ERK phosphorylation. Remarkably, berberine attenuated
myocardial dysfunction (91.292.93% vs. 76.251.66% in diabetic rats, n¼4,
P<0.01), cardiac ﬁbrosis (TGF-b mRNA, 48.885.69% vs. 21514.65% in diabetic
rats, n¼3, P<0.05), inﬂammation and interrelated signaling pathways respectively.
Furthermore, berberine also attenuated the TGF-b-induced increased cardiac ﬁbrosis
and inﬂammation signaling pathways in cultured ﬁbroblasts, which berberine effects
were blocked by AMPK inhibition.
Conclusions: These results suggested that berberine may have great therapeutic po-
tential in the treatment of diabetic complications, and perhaps other cardiovascular
disorders, by attenuating ﬁbrosis and inﬂammation.
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Objectives: Glutathione peroxidase-1 (GPx1) is a pivotal intracellular antioxidant
enzyme that enzymatically reduces hydrogen peroxide to water to limit its harmful
effects. Recent ﬁndings indicate that the lack of GPx1 contributes to the risk of
atherosclerosis and cardiovascular disease. This study aims to identify a microRNA
(miRNA) targeting GPx1 to maintain redox homeostasis.
Methods: The cultured H9c2 cells were treated with different concentrationof H2O2 for
2h.Then, CCK8 assay was used to determine cell viability and the extent of apoptosis
was detected by TUNEL assays. Exogenous H2O2 induced endogenous Gpx1 expres-
sion change in H9c2 cells was assesed byWestern blot. Dual luciferase assay combined
with mutation and immunoblotting was used to validate the bioinformatically predicted
miRNAs. H9c2 cells were transfected with miR-181a mimics or miR-181a inhibitor,
H2O2 (400 uM) was added for the last 2 h. H9c2 cells were divided into the following 6
groups. The changes of apoptosis in H9c2 cells were quantitatively assayed with
Annexin V and PI double staining by Flow cytometric. LDH and MDA were simulta-
neously measured. The changes in intracellular ROS was detected by DCFH-DA
staining. The measurement of mitochondrial membrane Potential was detected by using
JC-1 probe.The expression of Bcl-2, Bax, cleaved caspase-3 in H9c2 cells were detected
by Western blotting. Immunoﬂuorescent detection of intracellular cytochrome c local-
ization was used by ﬂuorescent microscopy.
Results: 400uM H2O2 damage the antioxidant enzymes system resulting in Gpx1
expression decreased (P<0.05). The intersection of three algorithms identiﬁed four
potential miRNAs candidates: miR-7a, 125a, 181a and 423. At the apoptotic concen-
tration of H2O2, only miR-181a expressions were increased compared with normal
group, whereas other’s expressions decreased (P<0.05). A signiﬁcant decrease in
relative luciferase activity was observed when pmiR-RB-Gpx1-3’-UTR was co-trans-
fected with miR-181a mimics as compared with the scrambled miRNAs, and the miR-
181a mimics-mediated suppression was abolished by the mutation of the 3’-UTR miR-
181a binding site. Comparedwith anti-CTL group, the release of LDH and the content of
MDA, the production of ROS, the apoptosis rates, Bax, cleaved caspase-3 expression
and the release of cytochrome c from the mitochondrial intermembrane space into the
cytoplasm were signiﬁcantly decreased in anti-miR-181a group (P<0.05) and the
expression of Bcl-2 and mitochondrial membrane potential was correspond increased in
anti-miR-181a group while upregulation of miR-181a exacerbated it (P<0.05).
Conclusions: we have demonstrated that the expression of miR-181a is up-regulated
in H2O2-treated H9c2 cells and that miR-181a inhibitor confers cardiac protection
against oxidative stress-induced H9c2 cells apoptosis through directly inhibiting the
Gpx1 expression and the ROS generation which maintains mitochondria membrane
integrity and inhibits the activation of mitochondrial apoptotic pathway under
oxidative stress conditions. These novel ﬁndings may have extensive implications for
the diagnosis and therapy of a variety of cardiovascular diseases related to ROS such
as atherosclerosis, hypertension, restenosis after angioplasty or bypass, diabetic
vascular complications, and transplantation arteriopathy.
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Medical University, HarbinJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BObjectives: Sonodynamic therapy (SDT) is known to decrease multiple cells viability,
and nerve stimulation reduces its activity and antagonizes the arrhythmias. The rapid
delayed rectiﬁer potassium channel (IKr) is involved in repolarization of cardiac ac-
tion potential. We investigated the effects of HMME-induced SDT on the biophysical
properties of IKr channel and the underlying structrue-activity relationships.
Methods: The effects of HMME-SDT were examined on the IKr channels in the
stable transfected HEK293 cells using a whole-cell patch clamp technique, western
blot analysis and immunoﬂuorescence experiment. The pharmacokinetics and tissue
distribution determination of HMME in rats were determined by a validated RP-HPLC
method.
Results: HMME-SDT induced decrease of current amplitude in time-dependent.
HMME-SDT reduced IKr tail current from 69.55.3 pA/pF in control group to
55.63.1 pA/pF in the 1 min group, 52.81.9 pA/pF (3 min) and 16.70.8 pA/pF (5
min); the corresponding current densities of HMME-SDT-treated cells were 39.82.9
pA/pF, 31.23.0 pA/pF and 15.90.7 pA/pF, respectively. HMME had binding af-
ﬁnity for the open and inactivated state of IKr channel. HMME distributed quickly in
rats, which was found to be in high concentration. HMME-SDT had no effect on the
generation and expression of IKr channels.
Conclusions: In conclusion, HMME-SDT is a potent way to block IKr channels, and
may be a potential treatment as an antiarrhythmic method.
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Objectives: Study was designed to determine the changes of voltage-gated K+ cur-
rents (Ikv) in the mesenteric arterial smooth muscle cells of rat during the gradual
apoptosis process by arsenic trioxide treatment.
Methods: Effect of arsenic trioxide on vascular smooth muscle cells was determined
by MTT assay. Apoptosis was evaluated by TUNEL method and voltage-gated K+
currents were recorded by whole-cell patch-clamp.
Results: Arsenic trioxide reduced vascular smooth muscle cell viability in a con-
centration-dependent manner after 48h exposure of the cells to 2-32 mmol/l arsenic
trioxide. Arsenic trioxide 8mmol/l (48h) induced apoptosis in the cultured mesenteric
arterial smooth muscle cells. Apoptosis ratio in arsenic trioxide 8 mmol/l (48h) in-
cubation group was 211.3% vs. 0.90.2% in control group (n¼5, P<0.05). This
concentration was used to treat the primary cultured mesenteric arterial smooth muscle
cells for 48h and the voltage-gated K+ currents currents densities (Ikv) was down-
regulated. The densities of the Ikv in 8 mmol/l arsenic trioxide groups were 4.180.85
pA/pF vs. 16.861.22 pA/pF in the control group at +60mv (n¼6, P<0.05).
Conclusions: Chronic As2O3 treatment induced vascular toxicity is mediated, at least
in part, by apoptosis of cultured mesenteric arterial SMCs. The densities of Ikv in
cultured mesenteric arterial smooth muscle cells down-regulated during the gradual
apoptotic process maybe a self-protective mechanism to reduce the loss by apoptotic
stimuli, and also accelerate vascular disease.
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Objectives: Arrhythmogenic right ventricular dysplasia (ARVD) is a genetically
determined disorder, characterized by two components, cardiomyopathy and
arrhythmia. To date, the ion channel-related pathogenesis underlying this phenomenon
has been poorly understood. The aim of this study was to systematically evaluate the
sodium channel variants in Chinese patients with ARVD.
Methods: Patients meeting the diagnostic guidelines of ARVD revised in 2010 were
enrolled. All exons and exon-intron boundaries of the SCN5A gene and desmosomal
genes known to be associated with ARVD, including DSC2, DSG2, DSP, JUP, and
PKP2 were sequenced by direct DNA sequencing.
Results: A total of 12 unrelated index patients were included. The eight of them
developed ventricular tachycardia (VT) and ventricular ﬁbrillation (VF), one of them
showed Epsilon wave, one of them showed type 1 Brugada wave, seven of them
exhibited syncope or dizziness, and none of the patients had a family history of SCD.
A new missense heterozygote mutation, I137M, in SCN5A was found in proband 5
with recurrent palpitations and a high incidence of VT. I137M is in exon 4 of SCN5A,
at the S1 segment in domain I of Nav1.5, and predicted a substitution of isoleucine for
methionine at codon site 137 (P. Ile137Met, I137M). I137M was not detected in 400
healthy control chromosomes from individuals of the same ethnic background, which
indicated that this mutation was a conservative site in the SCN5A gene, and the
encoded protein Nav1.5 might have a functional defect resulting in arrhythmia.
Conclusions: This study for the ﬁrst time systematically evaluated the sodium channel
variants in Chinese patients with ARVD, and found a new SCN5A mutation, I137M.
The result increases insight to the genetic pathogenesis of ARVD in Chinese patients,
and SCN5A genetic screening should be done in patients with ARVD and VT/VF.asic and Translational Medicine C65
